189 related articles for article (PubMed ID: 32097750)
1. Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy.
Guo S; Chen Y; Shi S; Wang X; Zhang H; Zhan Y; An H
Pharmacol Res; 2020 May; 155():104721. PubMed ID: 32097750
[TBL] [Abstract][Full Text] [Related]
2. Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects.
Guo S; Chen Y; Pang C; Wang X; Shi S; Zhang H; An H; Zhan Y
J Cell Physiol; 2019 Jun; 234(6):8698-8708. PubMed ID: 30370542
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TMEM16A Ca
Zhang X; Zhang G; Zhai W; Zhao Z; Wang S; Yi J
Pharmacol Res; 2020 Jun; 156():104763. PubMed ID: 32201246
[TBL] [Abstract][Full Text] [Related]
4. Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability.
Shi S; Ma B; Sun F; Qu C; An H
J Biol Chem; 2021 Sep; 297(3):101016. PubMed ID: 34329684
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma.
Guo S; Bai X; Liu Y; Shi S; Wang X; Zhan Y; Kang X; Chen Y; An H
Front Pharmacol; 2021; 12():643489. PubMed ID: 33935737
[No Abstract] [Full Text] [Related]
6. TMEM16A-inhibitor loaded pH-responsive nanoparticles: A novel dual-targeting antitumor therapy for lung adenocarcinoma.
Guo S; Qiu L; Chen Y; Wang X; Ma B; Qu C; Cui J; Zhang H; Xing C; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114062. PubMed ID: 32492446
[TBL] [Abstract][Full Text] [Related]
7. Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity.
Shi S; Ma B; Sun F; Qu C; Li G; Shi D; Liu W; Zhang H; An H
J Biol Chem; 2022 Mar; 298(3):101731. PubMed ID: 35176281
[TBL] [Abstract][Full Text] [Related]
8. Benzophenanthridine alkaloids suppress lung adenocarcinoma by blocking TMEM16A Ca
Zhang G; Zhu L; Xue Y; Zhao Z; Li H; Niu Z; Wang X; Chen P; Zhang J; Zhang X
Pflugers Arch; 2020 Oct; 472(10):1457-1467. PubMed ID: 32683500
[TBL] [Abstract][Full Text] [Related]
9. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.
Guo S; Bai X; Shi S; Deng Y; Kang X; An H
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681590
[TBL] [Abstract][Full Text] [Related]
10. Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy.
Zhang X; Zhang G; Zhao Z; Xiu R; Jia J; Chen P; Liu Y; Wang Y; Yi J
Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119132. PubMed ID: 34450215
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines.
Susanti S; Iwasaki H; Inafuku M; Taira N; Oku H
Phytomedicine; 2013 Dec; 21(1):39-46. PubMed ID: 24021157
[TBL] [Abstract][Full Text] [Related]
12. Drug repurposing and molecular mechanisms of the antihypertensive drug candesartan as a TMEM16A channel inhibitor.
Ji Q; Shi S; Ma B; Zhang W; An H; Guo S
Int J Biol Macromol; 2023 Apr; 235():123839. PubMed ID: 36842737
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of daidzein on the calcium-activated chloride channel TMEM16A and its anti-lung adenocarcinoma activity.
Wang X; Hao A; Song G; Elena V; Sun Y; Zhang H; Zhan Y; An H; Chen Y
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127261. PubMed ID: 37802433
[TBL] [Abstract][Full Text] [Related]
14. Arctigenin Protects against Lipopolysaccharide-Induced Pulmonary Oxidative Stress and Inflammation in a Mouse Model via Suppression of MAPK, HO-1, and iNOS Signaling.
Zhang WZ; Jiang ZK; He BX; Liu XB
Inflammation; 2015 Aug; 38(4):1406-14. PubMed ID: 25616905
[TBL] [Abstract][Full Text] [Related]
15. TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer.
Hu C; Zhang R; Jiang D
Arch Iran Med; 2019 Jan; 22(1):32-38. PubMed ID: 30821158
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
17. Anti‑metastatic effects of arctigenin are regulated by MAPK/AP‑1 signaling in 4T‑1 mouse breast cancer cells.
Lee MG; Lee KS; Nam KS
Mol Med Rep; 2020 Mar; 21(3):1374-1382. PubMed ID: 32016480
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
19. Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
Wang HQ; Jin JJ; Wang J
J Biochem Mol Toxicol; 2014 Jan; 28(1):39-45. PubMed ID: 24395429
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor evaluation of arctigenin derivatives based on antiausterity strategy.
Kudou N; Taniguchi A; Sugimoto K; Matsuya Y; Kawasaki M; Toyooka N; Miyoshi C; Awale S; Dibwe DF; Esumi H; Kadota S; Tezuka Y
Eur J Med Chem; 2013 Feb; 60():76-88. PubMed ID: 23287053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
